NovoCure Ltd. (NVCR)
17.08
+0.43
(+2.58%)
USD |
NASDAQ |
Jun 11, 14:37
NovoCure Shareholders Equity (Quarterly) : 330.72M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 330.72M |
| December 31, 2025 | 340.47M |
| September 30, 2025 | 341.33M |
| June 30, 2025 | 349.44M |
| March 31, 2025 | 361.96M |
| December 31, 2024 | 360.18M |
| September 30, 2024 | 360.78M |
| June 30, 2024 | 361.75M |
| March 31, 2024 | 359.36M |
| December 31, 2023 | 362.50M |
| September 30, 2023 | 393.70M |
| June 30, 2023 | 415.68M |
| March 31, 2023 | 432.15M |
| December 31, 2022 | 441.17M |
| September 30, 2022 | 445.40M |
| June 30, 2022 | 441.67M |
| March 31, 2022 | 435.88M |
| December 31, 2021 | 410.49M |
| September 30, 2021 | 413.16M |
| June 30, 2021 | 397.27M |
| March 31, 2021 | 372.13M |
| December 31, 2020 | 476.53M |
| September 30, 2020 | 307.04M |
| Date | Value |
|---|---|
| June 30, 2020 | 267.82M |
| March 31, 2020 | 241.95M |
| December 31, 2019 | 217.79M |
| September 30, 2019 | 190.36M |
| June 30, 2019 | 158.91M |
| March 31, 2019 | 126.39M |
| December 31, 2018 | 112.26M |
| September 30, 2018 | 114.94M |
| June 30, 2018 | 112.08M |
| March 31, 2018 | 106.12M |
| December 31, 2017 | 113.56M |
| September 30, 2017 | 116.68M |
| June 30, 2017 | 117.54M |
| March 31, 2017 | 128.90M |
| December 31, 2016 | 142.34M |
| September 30, 2016 | 158.24M |
| June 30, 2016 | 186.65M |
| March 31, 2016 | 220.43M |
| December 31, 2015 | 250.82M |
| September 30, 2015 | 121.22M |
| June 30, 2015 | 144.31M |
| March 31, 2015 | 76.42M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Smith & Nephew plc | -- |
| LivaNova Plc | 1.211B |
| Orchestra Biomed Holdings, Inc. | 50.96M |
| Accuray, Inc. | 41.71M |
| AstraZeneca PLC | 47.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 787.93M |
| Total Liabilities (Quarterly) | 457.21M |
| Debt to Equity Ratio | 0.7104 |
| Current Ratio | 2.903 |
| Net Debt Paydown Yield | 7.10% |